Pfizer

News

AZ builds in genomic medicine with $1bn Pfizer deal

AstraZeneca's rare diseases unit Alexion has agreed to pay $1 billion to acquire Pfizer's early-stage gene therapy pipeline and enabling technologies - the company's first

News

Supply impact of Pfizer’s tornado-hit plant less than feared

The FDA said it does not expect the damage to Pfizer’s Rocky Mount faci

News

Tornado-hit Pfizer facility could add to US drug shortages

The severe damage caused by a tornado to one of the largest facilities making sterile injectables in the US has raised fears it could exacerbate shortages of some medicine

News

Paul Biondi of Flagship's Pioneering Medicines

Pfizer inks $7bn strategic level R&D deal with Flagship

Pfizer has just made venture capital firm Flagship Pioneering a key component of its R&D engine, signing a deal worth up to $7 billion that will allow it to harvest ne

News

Beyfortus cleared by FDA for RSV prevention in infants

Sanofi’s plan to become a dominant player in the respiratory syncytial virus (RSV) market has moved a step closer, with FDA approval of Beyfortus for the prevention of RSV

News

BridgeBio rebounds on ATTR cardiomyopathy data

BridgeBio is getting ready to file for FDA approval of its acoramidis drug for transthyretin amyloidosis (ATTR) cardiomyopathy, armed with positive results in a phase 3 tr

AZ builds in genomic medicine with $1bn Pfizer deal

Supply impact of Pfizer’s tornado-hit plant less than feared

Tornado-hit Pfizer facility could add to US drug shortages

Pfizer inks $7bn strategic level R&D deal with Flagship

Beyfortus cleared by FDA for RSV prevention in infants

BridgeBio rebounds on ATTR cardiomyopathy data

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks